Search Results

NVP-ACC789 10 mg  | 99.19%

TargetMol

ACC-789 (NVP-ACC789; ZK-202650) is an effective, specific and orally active inhibitor of the VEGF receptor tyrosine kinases.

More Information Supplier Page

S107 5 mg  | 99.63%

TargetMol

S107 is a RyR-selective 1, 4-benzothiazepine derivative that stabilizes RyR2 channels by enhancing the binding affinity of calstabin2 to mutant and/or PKA-phosphorylated channels.

More Information Supplier Page

S107 50 mg  | 99.63%

TargetMol

S107 is a RyR-selective 1, 4-benzothiazepine derivative that stabilizes RyR2 channels by enhancing the binding affinity of calstabin2 to mutant and/or PKA-phosphorylated channels.

More Information Supplier Page

S107 10 mg  | 99.63%

TargetMol

S107 is a RyR-selective 1, 4-benzothiazepine derivative that stabilizes RyR2 channels by enhancing the binding affinity of calstabin2 to mutant and/or PKA-phosphorylated channels.

More Information Supplier Page

S107 100 mg  | 99.63%

TargetMol

S107 is a RyR-selective 1, 4-benzothiazepine derivative that stabilizes RyR2 channels by enhancing the binding affinity of calstabin2 to mutant and/or PKA-phosphorylated channels.

More Information Supplier Page

Dasotraline hydrochloride 10 mg  | 98.92%

TargetMol

Dasotraline hydrochloride (SEP-225289 hydrochloride) is a triple reuptake inhibitor that inhibits dopamine, norepinephrine, and serotonin transporters with IC50 values of 4, 6, and 11 nM, respectively.

More Information Supplier Page

Dasotraline hydrochloride 5 mg  | 98.92%

TargetMol

Dasotraline hydrochloride (SEP-225289 hydrochloride) is a triple reuptake inhibitor that inhibits dopamine, norepinephrine, and serotonin transporters with IC50 values of 4, 6, and 11 nM, respectively.

More Information Supplier Page